News

The patent, titled "Methods and Compositions for Oral Administrations of Proteins," covers a core concept of the company’s technology. Oramed CEO Nadav Kidron said, "The Japanese patent approval

The test was aimed at determining the dermal irritation potential of the spray as required by the FDA for biocompatibility. The biocompatibility study, which was conducted on the

Rockwell founder, chairman and CEO Robert Chioini said, "Coupled with the considerable clinical progress we continue to make with our iron-delivery drug SFP, we believe Rockwell is uniquely

According to the deal, SK Chemicals is responsible for clinical development, approval, and commercialization of THVD-201 and THVD-202 drug candidates to treat overactive bladder (OAB) and urge urinary

Under the agreement, Hovione will leverage Captisol technology in solubilization programs such as amorphous solid dispersions, crystal design and size reduction and control of particle size. Hovione particle

Acyclovir Ointment is the generic equivalent to Zovirax Ointment from Valeant International. Mylan has begun immediate product shipment. Zovirax Ointment is indicated for the management of initial genital

The collaboration will leverage BIND’s Medicinal Nanoengineering technology for the addition of tissue and cellular targeting capabilities to molecularly targeted drugs. BIND president and CEO Scott Minick said

The second CDI facility forms part of the $16m grant from California Institute of Regenerative Medicine (CIRM) to create and bank human induced pluripotent stem cells (iPSCs). Cellular

Achieved through a Type II variation, the production site approval will allow Pharming to supply the European market with drug substance from Sanofi Chimie. The approval will also